| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle Proteins | 23 | 2024 | 647 | 5.500 |
Why?
|
| Chromosomal Proteins, Non-Histone | 12 | 2024 | 214 | 4.220 |
Why?
|
| Separase | 11 | 2020 | 29 | 3.330 |
Why?
|
| Chromatids | 11 | 2024 | 43 | 2.450 |
Why?
|
| Nuclear Proteins | 11 | 2021 | 1267 | 1.740 |
Why?
|
| Endopeptidases | 7 | 2011 | 116 | 1.700 |
Why?
|
| Neoplasms | 8 | 2024 | 2770 | 1.680 |
Why?
|
| Aneuploidy | 8 | 2024 | 152 | 1.600 |
Why?
|
| DNA Repair | 5 | 2021 | 582 | 1.370 |
Why?
|
| DNA-Binding Proteins | 10 | 2021 | 2048 | 1.170 |
Why?
|
| Phosphoproteins | 7 | 2019 | 399 | 1.160 |
Why?
|
| Gonadotropin-Releasing Hormone | 11 | 2002 | 88 | 1.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2015 | 522 | 1.010 |
Why?
|
| Protein Subunits | 3 | 2015 | 164 | 0.950 |
Why?
|
| De Lange Syndrome | 2 | 2021 | 44 | 0.920 |
Why?
|
| Chromosome Segregation | 5 | 2024 | 62 | 0.880 |
Why?
|
| Benzimidazoles | 3 | 2020 | 128 | 0.840 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2021 | 274 | 0.760 |
Why?
|
| Hematopoiesis | 4 | 2023 | 220 | 0.740 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 1679 | 0.710 |
Why?
|
| Goldfish | 6 | 2002 | 8 | 0.690 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2020 | 39 | 0.690 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2013 | 243 | 0.680 |
Why?
|
| Oocytes | 7 | 2007 | 290 | 0.570 |
Why?
|
| Apoptosis | 5 | 2020 | 1783 | 0.560 |
Why?
|
| Ovarian Follicle | 7 | 2002 | 119 | 0.540 |
Why?
|
| Animals | 32 | 2023 | 33741 | 0.530 |
Why?
|
| Ovary | 9 | 2007 | 389 | 0.530 |
Why?
|
| Transcription Factors | 3 | 2021 | 2577 | 0.520 |
Why?
|
| Sister Chromatid Exchange | 2 | 2021 | 18 | 0.510 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 256 | 0.510 |
Why?
|
| Body Weight | 1 | 2019 | 999 | 0.500 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2011 | 715 | 0.490 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 1194 | 0.480 |
Why?
|
| Leukemia | 4 | 2011 | 376 | 0.480 |
Why?
|
| Antigens, Nuclear | 2 | 2019 | 61 | 0.470 |
Why?
|
| HeLa Cells | 5 | 2015 | 809 | 0.430 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2024 | 619 | 0.420 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 1875 | 0.390 |
Why?
|
| Meiosis | 7 | 2020 | 115 | 0.390 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2012 | 549 | 0.380 |
Why?
|
| Calpain | 1 | 2011 | 41 | 0.380 |
Why?
|
| Amino Acid Sequence | 8 | 2015 | 2698 | 0.380 |
Why?
|
| Receptors, LHRH | 6 | 2002 | 14 | 0.370 |
Why?
|
| Lymphoma, T-Cell | 1 | 2011 | 64 | 0.360 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 3871 | 0.360 |
Why?
|
| Lymphoma, B-Cell | 1 | 2011 | 135 | 0.340 |
Why?
|
| DNA Damage | 4 | 2021 | 507 | 0.340 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 991 | 0.340 |
Why?
|
| Fungal Proteins | 2 | 2002 | 134 | 0.330 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2009 | 87 | 0.320 |
Why?
|
| Oligopeptides | 1 | 2009 | 118 | 0.320 |
Why?
|
| Mice | 12 | 2023 | 17498 | 0.310 |
Why?
|
| Chromosomal Instability | 2 | 2008 | 58 | 0.310 |
Why?
|
| Humans | 34 | 2024 | 123199 | 0.290 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 207 | 0.290 |
Why?
|
| Protein Structure, Secondary | 2 | 2021 | 239 | 0.290 |
Why?
|
| Models, Biological | 2 | 2009 | 1442 | 0.270 |
Why?
|
| Binding Sites | 5 | 2013 | 1292 | 0.270 |
Why?
|
| Cell Line, Tumor | 8 | 2022 | 3289 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 1211 | 0.270 |
Why?
|
| Structure-Activity Relationship | 4 | 2016 | 568 | 0.260 |
Why?
|
| Enzyme Inhibitors | 4 | 2016 | 571 | 0.260 |
Why?
|
| Repressor Proteins | 3 | 2004 | 811 | 0.260 |
Why?
|
| Disease Progression | 1 | 2011 | 2027 | 0.240 |
Why?
|
| Metaphase | 3 | 2009 | 44 | 0.230 |
Why?
|
| Protein Binding | 3 | 2015 | 1743 | 0.230 |
Why?
|
| Maturation-Promoting Factor | 2 | 2000 | 10 | 0.230 |
Why?
|
| Testosterone | 4 | 2002 | 462 | 0.230 |
Why?
|
| Blotting, Western | 3 | 2013 | 1102 | 0.230 |
Why?
|
| Oncogenes | 3 | 2017 | 169 | 0.220 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2023 | 54 | 0.220 |
Why?
|
| Peptides | 4 | 2014 | 798 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 2 | 2001 | 28 | 0.210 |
Why?
|
| Ligases | 2 | 2001 | 46 | 0.210 |
Why?
|
| Breast Neoplasms | 3 | 2014 | 2487 | 0.200 |
Why?
|
| Female | 23 | 2020 | 65432 | 0.200 |
Why?
|
| Genomic Instability | 1 | 2024 | 229 | 0.200 |
Why?
|
| Progesterone | 2 | 2004 | 624 | 0.200 |
Why?
|
| Amino Acid Motifs | 2 | 2013 | 199 | 0.200 |
Why?
|
| Protein Kinases | 2 | 2000 | 330 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 3 | 2023 | 4352 | 0.200 |
Why?
|
| CDC2 Protein Kinase | 2 | 2012 | 35 | 0.200 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2013 | 757 | 0.200 |
Why?
|
| Arachidonic Acid | 1 | 2002 | 70 | 0.200 |
Why?
|
| Estrogens | 1 | 2004 | 507 | 0.190 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 1431 | 0.190 |
Why?
|
| Protein Kinase C | 1 | 2002 | 150 | 0.190 |
Why?
|
| Carcinogenesis | 1 | 2024 | 328 | 0.180 |
Why?
|
| Mammary Glands, Animal | 1 | 2004 | 482 | 0.180 |
Why?
|
| Sarcoma, Ewing | 1 | 2022 | 113 | 0.180 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 1695 | 0.180 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 198 | 0.180 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2021 | 423 | 0.180 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2012 | 66 | 0.180 |
Why?
|
| Conserved Sequence | 1 | 2021 | 293 | 0.180 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2020 | 28 | 0.180 |
Why?
|
| Cell Proliferation | 3 | 2014 | 2308 | 0.170 |
Why?
|
| Drug Stability | 1 | 2020 | 55 | 0.170 |
Why?
|
| Base Sequence | 4 | 2011 | 3093 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 537 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2020 | 124 | 0.160 |
Why?
|
| Gene Expression | 2 | 2021 | 1569 | 0.160 |
Why?
|
| DNA Replication | 1 | 2021 | 343 | 0.160 |
Why?
|
| Anaphase | 2 | 2009 | 20 | 0.160 |
Why?
|
| Blood Proteins | 1 | 1999 | 116 | 0.160 |
Why?
|
| Steroids | 1 | 2000 | 203 | 0.160 |
Why?
|
| Cyclic AMP | 1 | 1999 | 247 | 0.160 |
Why?
|
| Purines | 1 | 2019 | 107 | 0.160 |
Why?
|
| Aminopyridines | 1 | 2019 | 53 | 0.150 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2019 | 97 | 0.150 |
Why?
|
| Kinetics | 5 | 2009 | 1313 | 0.150 |
Why?
|
| Models, Molecular | 1 | 2021 | 1070 | 0.150 |
Why?
|
| Models, Animal | 1 | 2019 | 465 | 0.150 |
Why?
|
| Cell Survival | 1 | 2020 | 803 | 0.140 |
Why?
|
| Eosinophilia | 1 | 2019 | 101 | 0.140 |
Why?
|
| Mitosis | 2 | 2011 | 238 | 0.140 |
Why?
|
| Metallothionein | 1 | 1996 | 14 | 0.140 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 369 | 0.140 |
Why?
|
| Zinc | 1 | 1996 | 128 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1916 | 0.130 |
Why?
|
| Barrett Esophagus | 1 | 2020 | 341 | 0.130 |
Why?
|
| Maximum Tolerated Dose | 2 | 2014 | 157 | 0.130 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2015 | 7 | 0.120 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 60 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2015 | 3050 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 520 | 0.120 |
Why?
|
| ErbB Receptors | 1 | 1996 | 284 | 0.120 |
Why?
|
| Rhodamines | 1 | 2014 | 22 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 75 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2012 | 612 | 0.110 |
Why?
|
| Hydrolysis | 1 | 2014 | 155 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 350 | 0.110 |
Why?
|
| Sf9 Cells | 1 | 2013 | 9 | 0.110 |
Why?
|
| Mutation | 5 | 2022 | 5778 | 0.110 |
Why?
|
| Spodoptera | 1 | 2013 | 44 | 0.110 |
Why?
|
| Collagen | 1 | 2015 | 313 | 0.110 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 106 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 96 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2021 | 3717 | 0.110 |
Why?
|
| Rats | 1 | 2020 | 3631 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 532 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 85 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2008 | 2820 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 462 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2013 | 112 | 0.110 |
Why?
|
| Binding, Competitive | 5 | 1997 | 179 | 0.110 |
Why?
|
| Protein Stability | 1 | 2013 | 167 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2013 | 122 | 0.110 |
Why?
|
| Cell Line | 3 | 2013 | 2779 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 330 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2015 | 527 | 0.100 |
Why?
|
| Antibodies | 1 | 2014 | 370 | 0.100 |
Why?
|
| Carps | 1 | 1992 | 10 | 0.100 |
Why?
|
| S Phase | 1 | 2012 | 73 | 0.100 |
Why?
|
| Prophase | 1 | 2011 | 4 | 0.100 |
Why?
|
| Epithelial Cells | 2 | 2008 | 901 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 111 | 0.100 |
Why?
|
| Osmolar Concentration | 4 | 1997 | 172 | 0.100 |
Why?
|
| Cyclin B | 1 | 2011 | 23 | 0.100 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 574 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2011 | 76 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 2391 | 0.100 |
Why?
|
| Thymus Neoplasms | 1 | 2011 | 29 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 1684 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 359 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2013 | 674 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 576 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2011 | 284 | 0.090 |
Why?
|
| Ubiquitins | 2 | 2001 | 42 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 657 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 389 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 450 | 0.090 |
Why?
|
| Longevity | 1 | 2011 | 138 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 651 | 0.080 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2009 | 20 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1390 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2011 | 322 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2009 | 28 | 0.080 |
Why?
|
| Enzyme Stability | 1 | 2009 | 58 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 665 | 0.080 |
Why?
|
| Dacarbazine | 1 | 2009 | 86 | 0.080 |
Why?
|
| Xenopus laevis | 1 | 2009 | 122 | 0.080 |
Why?
|
| Chromatin | 1 | 2012 | 552 | 0.080 |
Why?
|
| Genetic Complementation Test | 1 | 2008 | 86 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2011 | 742 | 0.080 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 134 | 0.080 |
Why?
|
| Male | 8 | 2020 | 60021 | 0.080 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2009 | 99 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 649 | 0.080 |
Why?
|
| Macromolecular Substances | 1 | 2009 | 185 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2011 | 475 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 157 | 0.080 |
Why?
|
| Tetracycline | 1 | 2008 | 78 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2009 | 619 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 931 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 396 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4268 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2011 | 1611 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2008 | 228 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2008 | 140 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 1999 | 463 | 0.070 |
Why?
|
| Meiotic Prophase I | 1 | 2007 | 1 | 0.070 |
Why?
|
| Rad51 Recombinase | 1 | 2007 | 30 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2011 | 847 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2007 | 48 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1021 | 0.070 |
Why?
|
| Algorithms | 1 | 2013 | 1597 | 0.070 |
Why?
|
| Pyrazines | 1 | 2007 | 73 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 1063 | 0.070 |
Why?
|
| Calcium | 1 | 2011 | 1096 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 1305 | 0.070 |
Why?
|
| Osteosarcoma | 1 | 2008 | 257 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2007 | 441 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1582 | 0.060 |
Why?
|
| Mad2 Proteins | 1 | 2004 | 9 | 0.060 |
Why?
|
| Logistic Models | 1 | 2009 | 1799 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 573 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1996 | 424 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2008 | 427 | 0.060 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 2 | 2001 | 20 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2007 | 262 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 13 | 0.050 |
Why?
|
| Caspase Inhibitors | 1 | 2002 | 29 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 327 | 0.050 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2001 | 35 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2002 | 48 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 123 | 0.050 |
Why?
|
| Etoposide | 1 | 2002 | 117 | 0.050 |
Why?
|
| 5,8,11,14-Eicosatetraynoic Acid | 1 | 2002 | 2 | 0.050 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2002 | 6 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 1338 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 69 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 317 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 1002 | 0.050 |
Why?
|
| Caspases | 1 | 2002 | 159 | 0.050 |
Why?
|
| Phenotype | 1 | 2011 | 4225 | 0.050 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2001 | 64 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2002 | 623 | 0.050 |
Why?
|
| Testis | 2 | 2007 | 405 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2001 | 353 | 0.040 |
Why?
|
| Salmon | 3 | 1997 | 5 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1998 | 333 | 0.040 |
Why?
|
| Activating Transcription Factors | 1 | 1999 | 4 | 0.040 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 1999 | 25 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 91 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 1999 | 114 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 38 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 54 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1684 | 0.040 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1998 | 4 | 0.040 |
Why?
|
| Tissue Extracts | 1 | 1998 | 13 | 0.040 |
Why?
|
| Spermatogenesis | 1 | 1999 | 166 | 0.040 |
Why?
|
| Sequence Homology | 1 | 1998 | 62 | 0.040 |
Why?
|
| Cell Division | 2 | 2001 | 779 | 0.040 |
Why?
|
| Lampreys | 1 | 1997 | 1 | 0.040 |
Why?
|
| Pituitary Gland | 1 | 1998 | 84 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 893 | 0.040 |
Why?
|
| Time Factors | 2 | 2000 | 6201 | 0.040 |
Why?
|
| G2 Phase | 1 | 1997 | 45 | 0.040 |
Why?
|
| Perciformes | 1 | 1997 | 6 | 0.040 |
Why?
|
| Radiation Tolerance | 1 | 1997 | 52 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 1997 | 212 | 0.030 |
Why?
|
| Hydroxyprogesterones | 1 | 1996 | 6 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 1997 | 204 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1996 | 27 | 0.030 |
Why?
|
| Gonadotropins | 1 | 1996 | 36 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1997 | 347 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1996 | 122 | 0.030 |
Why?
|
| Thymidine | 1 | 1995 | 53 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 103 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 98 | 0.030 |
Why?
|
| Fishes | 1 | 1995 | 41 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 1997 | 370 | 0.030 |
Why?
|
| Catfishes | 1 | 1994 | 1 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1997 | 554 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 804 | 0.030 |
Why?
|
| Diploidy | 1 | 2013 | 35 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 231 | 0.030 |
Why?
|
| Mammals | 1 | 1995 | 262 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2000 | 1480 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 142 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 217 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 172 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1005 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 868 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1992 | 141 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2013 | 357 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 540 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1992 | 966 | 0.020 |
Why?
|
| DNA Mismatch Repair | 1 | 2009 | 48 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2009 | 241 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2008 | 25 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 92 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2007 | 22 | 0.020 |
Why?
|
| DNA, Cruciform | 1 | 2007 | 18 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 60 | 0.020 |
Why?
|
| Bortezomib | 1 | 2007 | 73 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2007 | 312 | 0.020 |
Why?
|
| Infertility | 1 | 2007 | 90 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1083 | 0.020 |
Why?
|
| Temperature | 2 | 1997 | 306 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 815 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2007 | 459 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 614 | 0.010 |
Why?
|
| Cell Membrane | 2 | 1997 | 459 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 767 | 0.010 |
Why?
|
| Sex Factors | 1 | 2007 | 1257 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 1607 | 0.010 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2001 | 30 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 2001 | 145 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 678 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 29038 | 0.010 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 1997 | 6 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1997 | 80 | 0.010 |
Why?
|
| Ovulation | 1 | 1997 | 113 | 0.010 |
Why?
|
| Reproduction | 1 | 1997 | 243 | 0.010 |
Why?
|
| Estradiol | 1 | 1997 | 534 | 0.010 |
Why?
|
| Child | 2 | 2007 | 24208 | 0.010 |
Why?
|
| Chickens | 1 | 1994 | 636 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 12323 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 13862 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 19086 | 0.000 |
Why?
|